Yes plus:
Anticipated run-rate monthly operating cash costs of ~$65m
and why would they think about this: Exploring possible sale of Melbourne head office site (~$60m).
I didn't expect doubling the share issue but I guess they rather have enough cash for the rest of the year than come back to the market and ask again. Tough times and no doubt this will take years to fix.
- Forums
- ASX - By Stock
- FLT
- Equity raise process
Equity raise process, page-29
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FLT (ASX) to my watchlist
|
|||||
Last
$22.56 |
Change
0.610(2.78%) |
Mkt cap ! $4.986B |
Open | High | Low | Value | Volume |
$22.20 | $22.61 | $21.97 | $28.02M | 1.252M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2440 | $22.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.57 | 8445 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 629 | 23.680 |
1 | 48 | 23.170 |
4 | 400 | 23.040 |
4 | 1109 | 22.560 |
1 | 400 | 22.550 |
Price($) | Vol. | No. |
---|---|---|
21.400 | 933 | 1 |
21.440 | 11 | 1 |
21.800 | 10 | 1 |
21.830 | 16 | 1 |
22.040 | 385 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
FLT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online